用于治疗严重的有氧格拉姆阴性细菌感染的Cefiderocol:技术评估,以启动一种新的订阅式支付模式
Beth Woods1, Laetitia Schmitt1, Dina Jankovic1
1Centre for Health Economics, University of York, York, UK.
Health technology assessment (Winchester, England)
|June 28, 2024
概括
这项研究评估了塞菲德罗科尔对英格兰严重格兰阴性感染的健康益处. 结果显示了显著的不确定性,但估计在20年内可能获得8963559个质量调整后寿命年.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 抗微生物药物管理管理
背景情况:
- 需要针对抗微生物药物的创新融资模式,从基于数量的评估转向基于价值的评估.
- 塞菲德罗科尔是一种新型抗菌药物,用于治疗严重的有氧格兰氏阴性细菌感染.
- 评估人口层面的健康益处为国家健康指导和商业合同提供了信息.
研究的目的:
- 评估英格兰NHS中塞菲德罗科尔在人口水平上的健康益处.
- 为国家卫生和护理卓越研究所 (NICE) 的指导提供信息.
- 为了支持制造商和英格兰NHS之间的合同价值讨论.
主要方法:
- 网络元分析合成了关于抗菌素易感性的证据.
- 决策建模量化了患者层面的成本和健康结果 (质量调整的寿命年).
- 根据感染预测,在20年内预测出人口层面的好处.
主要成果:
- 患者层面的益处在0.02至0.15的质量调整寿命年之间.
- 在不同情景中,人口层面的好处差异很大 (8963559个20年质量调整寿命年).
- 关于塞菲德罗科尔的益处和适合感染人数的高度不确定性.
结论:
- 在预期的NHS使用范围内,提供了对 cefiderocol 的定量估计值.
- 该研究强调了与当前证据相关的重大不确定性.
- 对于未来的抗微生物药物评估,建议改进数据链接和建模.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...


